Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery [NA]
A completed clinical trial evaluating a rapid triadic communication intention elicitation intervention to improve supportive oncology care d…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer [NA]
The clinical trial MicroFluO evaluating fluorescence-guided surgery for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) [Phase 2]
Phase 2 pilot trial evaluating rosuvastatin plus enoxaparin for thromboprophylaxis after ovarian cancer surgery has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer [Phase 1]
A Phase 1 trial from the University of Michigan evaluates talazoparib in combination with belinostat in metastatic breast cancer, metastatic…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]
A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors [Phase 1]
Phase 1 study of ELI-002 in KRAS-mutated pancreatic ductal adenocarcinoma and other KRAS-driven solid tumors has completed enrollment, with …
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) [Phase 2]
A Phase 2 trial called Newton (NEW Dosing Maintenance Therapy Ovarian Cancer) sponsored by the Mario Negri Institute has been terminated. Th…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. [Phase 1]
Phase 1 clinical trial update for COM701, a PVRIG inhibitor, in adults with advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer [NA]
A completed multi-site trial evaluating a perioperative care pathway to reduce complications in patients with ovarian cancer and related gyn…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib [Phase 2]
Phase 2 trial evaluating the combination of cediranib and olaparib for recurrent ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer [Phase 2]
This is a completed Phase 2 clinical trial evaluating bevacizumab in combination with tocotrienol for recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations [Phase 1]
Phase I clinical trials are evaluating Axitinib for potential efficacy in patients with BRCA1/2 mutations, including breast and ovarian canc…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral AMXT 1501 Dicaprate in Combination With IV DFMO [Phase 1, Phase 2]
A Phase 1/2 trial of oral AMXT 1501 dicaprate in combination with IV DFMO has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer [Phase 2]
A Phase 2 clinical trial of niraparib as neoadjuvant therapy for unresectable ovarian cancer is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating Caelyx (liposomal doxorubicin) given biweekly in heavily pretreated patients with relapsed ovarian …
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 trial evaluating NC410 in combination with pembrolizumab for advanced unresectable or metastatic solid tumors across mul…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluates Fluzoparib with or without Bevacizumab as neoadjuvant therapy for advanced ovarian cancer, with recruitme…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. [Phase 1]
A Phase I/Ib trial of NZV930 alone and in combination with PDR001 and/or NIR178 in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib. [Phase 4]
Phase 4 real-world study assessing tolerability and quality of life for niraparib in ovarian cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating Avatar-Directed Chemotherapy for recurrent fallopian tube cancer, ovarian cancer, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months [Phase 1, Phase 2]
Phase 1/2 trial evaluating AsiDNA, a DNA repair inhibitor, in combination with PARP inhibitors for relapsed platinum-sensitive ovarian cance…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: FPA150 in Patients With Advanced Solid Tumors [EARLY_Phase 1]
This early-phase 1 trial of FPA150 in breast cancer, ovarian cancer, and endometrial cancer has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR) [Phase 1]
This document reports the completion status of a Phase 1 clinical trial of IMAB027 in patients with recurrent advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
This clinical trial update reports completion of a study investigating homologous recombination in ovarian cancers, including ovarian cancer…